FDA
-
-
-
-
-
-
-
Sonoma Pharmaceuticals registers facility under FDA cosmetic rules
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Reports FDA Approval for Antimicrobial Post-Therapy Gel
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Gains 20% Pre-Market on FDA Clearance for Loyon
-
-
-
-
330,366 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

